Company: SHPH
Filing Date: 2025-08-13
Form Type: 10-Q
Source: 0001641172-25-023263
Chunk: 11

Company: Shuttle Pharmaceuticals Holdings, Inc.
Filing Date: 2025-08-13
Form: 10-Q
Item: Part II, Item 1A
Chunk 11
---
 101.INS
     
    Inline
    XBRL Document Set for the financial statements and accompanying notes in Part I, Item 1, of this Quarterly Report on Form 10-Q.
  
    104
     
    Cover
    Page Interactive Data File (embedded within the Inline XBRL document)

*
Filed herewith.

**Furnished
herewith.

33

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to
be signed on its behalf by the undersigned thereunto duly authorized.

    SHUTTLE
    PHARMACEUTICALS HOLDINGS, INC.

    August 12,
2025
    By:
    /s/
    Christopher Cooper

    Christopher
    Cooper

    Interim
    Chief Executive Officer

    (Principal
    Executive Officer)

    August 12,
    2025
    By:
    /s/
    Timothy J. Lorber

    Timothy
    J. Lorber

    Chief
    Financial Officer

    (Principal
    Financial and Accounting Officer)

34